Leerink Partnrs Issues Positive Outlook for EHC Earnings

Encompass Health Co. (NYSE:EHC) – Equities researchers at Leerink Partnrs raised their Q1 2025 earnings estimates for Encompass Health in a report issued on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $1.26 per share for the quarter, up from their previous estimate of $1.21. The consensus estimate for Encompass Health’s current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Encompass Health’s Q3 2025 earnings at $1.15 EPS, Q4 2025 earnings at $1.30 EPS, FY2025 earnings at $4.90 EPS, Q1 2026 earnings at $1.29 EPS, Q3 2026 earnings at $1.17 EPS, Q4 2026 earnings at $1.34 EPS and FY2026 earnings at $5.01 EPS.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%.

Several other equities analysts also recently issued reports on the stock. Truist Financial reaffirmed a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Barclays lifted their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. StockNews.com downgraded Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday, February 7th. Finally, KeyCorp lifted their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $107.67.

Encompass Health Stock Up 0.7 %

Shares of NYSE EHC opened at $99.37 on Wednesday. The company has a 50 day simple moving average of $96.14 and a 200 day simple moving average of $95.41. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health has a 1 year low of $72.38 and a 1 year high of $104.55. The firm has a market cap of $10.01 billion, a PE ratio of 22.28, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90.

Institutional Investors Weigh In On Encompass Health

Several large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in shares of Encompass Health by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock valued at $960,817,000 after acquiring an additional 138,196 shares in the last quarter. State Street Corp grew its holdings in Encompass Health by 0.7% in the third quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after purchasing an additional 21,329 shares during the period. Geode Capital Management LLC increased its stake in Encompass Health by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after purchasing an additional 20,547 shares in the last quarter. Copeland Capital Management LLC raised its holdings in shares of Encompass Health by 0.7% during the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock valued at $119,418,000 after purchasing an additional 8,548 shares during the period. Finally, Thrivent Financial for Lutherans boosted its position in shares of Encompass Health by 16.9% during the 4th quarter. Thrivent Financial for Lutherans now owns 888,827 shares of the company’s stock worth $82,083,000 after purchasing an additional 128,331 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.